Phase 1B Pilot Safety Study of LiRIS-TM, A Novel Bladder Drug Delivery Platform in Patients With Interstitial Cystitis.
Phase of Trial: Phase I
Latest Information Update: 17 Dec 2014
At a glance
- Drugs Lidocaine (Primary)
- Indications Interstitial cystitis
- Focus Adverse reactions
- Sponsors Allergan
- 07 Nov 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 07 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Apr 2011 NCT reports planned end date as 1 Aug 2011.